SARS (Severe Acute Respiratory Syndrome) Withdrawn Phase 3 Trials for Hydroxychloroquine (DB01611)

Also known as: Severe Acute Respiratory Syndrome (SARS) / Severe Acute Respiratory Syndrome / Respiratory Syndrome, Acute, Severe / SARS (Disease) / SARS-CoV-1 infection / SARS / Severe acute respiratory syndrome (disorder) / Severe acute respiratory syndrome NOS

DBCOND0127071 (SARS (Severe Acute Respiratory Syndrome))Withdrawn3 IdentifierTitlePurposeDrugs
NCT04361461Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)Treatment